Guided Therapeutics (GTHP) Return on Sales (2010 - 2026)
Guided Therapeutics (GTHP) posted Return on Sales of 0.02% for Q4 2025, up 83.31% sequentially from 0.12% in Q3 2025, and up 650.0% YoY from 0.0% in Q4 2024.
Guided Therapeutics (GTHP) Return on Sales (2010 - 2026) Analysis & Trends
Guided Therapeutics has reported Return on Sales for 16 years, with the latest figure at 0.02% in Q4 2025.
- Quarterly Return on Sales rose 650.0% year-over-year to 0.02% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.04% (up 341.0% YoY) and the FY2025 annual result came in at 0.04%, up 341.0% from the prior year.
- Return on Sales rose to 0.02% in Q4 2025 per GTHP's latest filing, from 0.12% in the prior quarter.
- Over five years, Return on Sales peaked at 0.04% in Q3 2021 and troughed at 24.42% in Q1 2025.
- A 5-year average of 2.5% and a median of 0.57% in 2024 frame the typical range for Return on Sales.
- The widest YoY moves for Return on Sales: up 650 bps in 2025, down 2375 bps in 2025.
- Over 5 years, Return on Sales stood at 0.07% in 2021, then sank by 4414 bps to 3.34% in 2022, then jumped by 96 bps to 0.12% in 2023, then plunged by 5305 bps to 6.52% in 2024, then soared by 100 bps to 0.02% in 2025.
- According to Business Quant data, Return on Sales over the past three periods registered 0.02%, 0.12%, and 0.07% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 0.00% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 0.00% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 0.00% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 0.00% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 0.00% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 0.00% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 0.00% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 0.00% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 0.00% |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | -0.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.04% |
| Dec 31, 2025 | -0.02% |
| Sep 30, 2025 | -0.12% |
| Jun 30, 2025 | -0.07% |
| Mar 31, 2025 | -24.42% |
| Dec 31, 2024 | -6.52% |
| Sep 30, 2024 | -0.57% |
| Jun 30, 2024 | -0.57% |
| Mar 31, 2024 | -0.67% |
| Dec 31, 2023 | -0.12% |
| Sep 30, 2023 | -0.74% |
| Jun 30, 2023 | -0.35% |
| Mar 31, 2023 | -0.40% |
| Dec 31, 2022 | -3.34% |
| Sep 30, 2022 | -3.67% |
| Jun 30, 2022 | -1.85% |
| Mar 31, 2022 | -1.01% |
| Dec 31, 2021 | -0.07% |
| Sep 30, 2021 | 0.04% |
| Jun 30, 2021 | -5.17% |